{"id":"F2007B01104","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 12 of 1998)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":67865,"registerId":"commonwealth-F2007B01104-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 12 of 1998)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 12 of 1998\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration shall come into operation on 17 June 1998.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nMibefradil Dihydrochloride\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nDated this 10th day of June 1998.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Family Services\n\nDelegate of the Minister for Health and Family Services","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1615},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The declaration exercises the specific power in subsection 85(2AA) of the National Health Act 1953 exactly as intended—to remove specified drugs from the Pharmaceutical Benefits Scheme. It has not expanded beyond this original purpose."},"complexity_factors":["Single drug listed in the Schedule (Mibefradil Dihydrochloride only)","No defined terms within the instrument itself","No cross-references, exceptions, or conditional provisions","Extremely short length (approximately 200 words)","Simple binary operation: the named drug is removed from PBS coverage"],"plain_english_summary":"This declaration removes the heart drug Mibefradil Dihydrochloride (Posicor) from the Pharmaceutical Benefits Scheme, so from 17 June 1998 it no longer receives PBS subsidy. Patients, prescribers and pharmacists are affected: government funding stops, patients must pay privately or change treatment, reflecting the drug’s global safety withdrawal for dangerous interactions."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-12-of-1998/documents"}}